| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 02/09/2000 | EP0977850A1 Edg-1-like receptor |
| 02/09/2000 | EP0977849A1 Leukemia associated genes |
| 02/09/2000 | EP0977843A1 Novel human transmembrane 4 superfamily protein |
| 02/09/2000 | EP0977842A1 Cash (caspase homologue) with death effector domain, modulators of the function of fas receptors |
| 02/09/2000 | EP0977834A2 Human serine protease precursor |
| 02/09/2000 | EP0977777A1 A novel th2-specific gene |
| 02/09/2000 | EP0977756A1 PYRAZOLOPYRIMIDINONES WHICH INHIBIT TYPE 5 CYCLIC GUANOSINE 3',5'-MONOPHOSPHATE PHOSPHODIESTERASE (cGMP PDE5) FOR THE TREATMENT OF SEXUAL DYSFUNCTION |
| 02/09/2000 | EP0977751A1 Somatostatin agonists |
| 02/09/2000 | EP0977750A1 Farnesyltransferase inhibiting quinazolinones |
| 02/09/2000 | EP0977749A1 Bi-aromatic compounds and pharmaceutical and cosmetic compositions containing same |
| 02/09/2000 | EP0977745A1 Thioaryl sulfonamide hydroxamic acid compounds |
| 02/09/2000 | EP0977738A2 Cyclin dependent kinase (cdk)4 inhibitors and their use for treating cancer |
| 02/09/2000 | EP0977735A1 Vitronectin receptor antagonists |
| 02/09/2000 | EP0977733A1 Arylsulfonylamino hydroxamic acid derivatives |
| 02/09/2000 | EP0977725A1 New fatty acid derivatives |
| 02/09/2000 | EP0977595A1 Prevention of graft-versus-host disease with t-cells including polynucleotides encoding negative selective markers |
| 02/09/2000 | EP0977592A1 Method for improved selectivity in photo-activation of molecular agents |
| 02/09/2000 | EP0977591A1 Costimulation of t-cell proliferation by a chimeric bispecific costimulatory protein |
| 02/09/2000 | EP0977589A1 Adjuvant compositions for vaccines |
| 02/09/2000 | EP0977579A1 Gastrin receptor-avid peptide conjugates |
| 02/09/2000 | EP0977562A1 Methods and compositions for delivery of taxanes |
| 02/09/2000 | EP0977559A1 Enhanced anti-cancer agent delivery to solid tumors by primer compounds |
| 02/09/2000 | EP0977557A1 Pellet-type formulation intended for treating the intestinal tract |
| 02/09/2000 | CN1244197A Tetrahydrofuran derivatives |
| 02/09/2000 | CN1244124A Amorphous benzothiophenes, methods of preparation, and methods of use |
| 02/09/2000 | CN1244123A Kit for inhibiting the growth of cancers, comprising a chemotherapeutic agent and a benzimdazole, and optionally a protentiator |
| 02/09/2000 | CN1244122A Method of using cyclooxygenase-2 inhibitors in the treatment and prevention of neoplasia |
| 02/09/2000 | CN1243827A Preparation of heterocyclic amide derivative with specific physical status |
| 02/09/2000 | CN1243826A Antihypertensive and anticancer compound, its preparing process and its application in medicine |
| 02/09/2000 | CN1243750A Genetically engineered drug for preventing cancer metastasis and its preparing process |
| 02/09/2000 | CN1243749A Inhibitor |
| 02/09/2000 | CN1243748A Anticancer action of cell factor derivative |
| 02/09/2000 | CN1243721A Medicinal pill for treating leukemia |
| 02/09/2000 | CN1243716A Medicine for preventing and curing malignant tumor |
| 02/09/2000 | CN1243709A Injection for treating tumor in respiratory system and its application |
| 02/09/2000 | CN1243707A Injection for treating gynecologic tumor and lymphomatosis and its application |
| 02/09/2000 | CN1243706A Injection for treating tumor in digestive system and its application |
| 02/09/2000 | CN1049215C Pharmaceutical compounds |
| 02/09/2000 | CN1049214C Phenylimidazolidines, process for their preparation, their use as medicament and pharmaceutical compositions containing them. |
| 02/08/2000 | US6022978 Benzimidazole derivatives |
| 02/08/2000 | US6022960 Nucleotide sequence coding a chimeric gonadotropin releasing hormone; for vaccine development |
| 02/08/2000 | US6022900 Preventing and ameliorating cachexia; treating whole body nitrogen loss associated with catabolic illness by inhibiting synthesis of urea from plasma arginine |
| 02/08/2000 | US6022899 Effective inhibitors of the cellular sodium proton antiporter |
| 02/08/2000 | US6022898 Metalloproteinase inhibitors |
| 02/08/2000 | US6022892 Bis-platinum complexes with polyamine ligands as antitumor agents |
| 02/08/2000 | US6022884 Substituted pyridine compounds and methods of use |
| 02/08/2000 | US6022876 L-β-dioxolane uridine analogs and methods for treating and preventing Epstein-Barr virus infections |
| 02/08/2000 | US6022873 Metalloproteinase inhibitors |
| 02/08/2000 | US6022860 Immobilized and activity-stabilized complexes of LHRH antagonists and processes for their preparation |
| 02/08/2000 | US6022848 Inhibitor of stem cell proliferation and uses thereof |
| 02/08/2000 | US6022735 Composition for introducing nucleic acid complexes into higher eucaryotic cells |
| 02/08/2000 | US6022692 Diagnosis of cancer in humans; screening sample with nucleotide sequences associated with cancer, hybridizing, the formation of hybridization complexes is indicative of cancer potential |
| 02/08/2000 | US6022541 Immunological preparation for concurrent specific binding to spatially exposed regions of vascular permeability factor bound in-vivo to a tumor associated blood vessel |
| 02/08/2000 | US6022538 Administering adriamycin or cisplatin, and cell therapy cells modified by in vitro treatment with a cytokine and gamma irradiation at a dose to irreversibly arrest cell proliferation but not interfere with the cytotoxic activity |
| 02/08/2000 | CA2127677C 2-bromo- and 2-nitroxy derivatives of 3-bromo- and 3.3-dibromo-4-oxo-azetidines, processes for the preparation thereof and use thereof |
| 02/08/2000 | CA2090942C Anti-tumour compounds containing quinazoline and tetrazole rings |
| 02/08/2000 | CA1340892C Bisplatinum complexes as chemotherapeutic agents |
| 02/03/2000 | WO2000005393A2 A polynucleotide comprising a ubiquitous chromatin opening element (ucoe) |
| 02/03/2000 | WO2000005388A1 Genes of the dead box protein family, their expression products and use |
| 02/03/2000 | WO2000005375A1 Gbs toxin receptor |
| 02/03/2000 | WO2000005374A2 Molecules associated with cell proliferation |
| 02/03/2000 | WO2000005371A1 Keratinocyte derived interferon |
| 02/03/2000 | WO2000005369A2 Nucleotide sequences and amino acid sequences of secreted proteins involved in angiogenesis |
| 02/03/2000 | WO2000005362A1 Mekk1(serine threonine kinases)-interacting fha (forkhead associated domain) protein 1 (mif1) |
| 02/03/2000 | WO2000005359A1 Use of prohibitin rna in treatment of cancer |
| 02/03/2000 | WO2000005269A1 Polymer complexes of glucuronoglucanes |
| 02/03/2000 | WO2000005268A1 Hybrid human/rodent igg antibody to cd3, and methods of its construction |
| 02/03/2000 | WO2000005259A1 Secreted cysteine rich protein-6 (scrp-6) |
| 02/03/2000 | WO2000005245A2 Inhibitors of urokinase and blood vessel formation |
| 02/03/2000 | WO2000005244A1 HUMAN BOMBESIN RECEPTOR SUBTYPE-3sb |
| 02/03/2000 | WO2000005225A1 Biphenyl derivatives |
| 02/03/2000 | WO2000005217A1 Imidazole compounds and their use as adenosine deaminase inhibitors |
| 02/03/2000 | WO2000005207A1 Substituted phenylamidines with antithrombotic action |
| 02/03/2000 | WO2000004954A2 Novel urokinase inhibitors |
| 02/03/2000 | WO2000004939A1 Dental pin |
| 02/03/2000 | WO2000004937A1 Flat flexible materials |
| 02/03/2000 | WO2000004925A1 Slow release formulations comprising anionic polysaccharide |
| 02/03/2000 | WO2000004923A1 Scrp-5: secreted cysteine rich protein-5 |
| 02/03/2000 | WO2000004921A1 Avian leukosis virus subgroup j envelope gene product for diagnosis and vaccine |
| 02/03/2000 | WO2000004918A2 Agents for the immunotherapy of tumoral diseases |
| 02/03/2000 | WO2000004911A1 Bovine excretion extracts having anticancer and anti-inflammatory activity and process for preparing the same |
| 02/03/2000 | WO2000004910A2 Low molecular weight components of shark cartilage, processes for their preparation and therapeutic uses thereof |
| 02/03/2000 | WO2000004907A1 An antilipemic formulation |
| 02/03/2000 | WO2000004894A2 Treatment regimen for administration of phenylacetylglutamine, phenylacetylisoglutamine, and/or phenylacetate |
| 02/03/2000 | WO2000004891A2 Anti-ulcer composition |
| 02/03/2000 | WO2000004882A1 Formulations of anionic polysaccharides |
| 02/03/2000 | WO2000004880A1 A wet granulation method for preparing a stable pharmaceutical formulation |
| 02/03/2000 | WO2000004878A1 Pharmaceutical composition in particular for preventing and treating mucositis induced by radiotherapy or chemotherapy |
| 02/03/2000 | WO2000004877A1 Suppository formulations comprising anionic polysaccharide |
| 02/03/2000 | WO2000004866A2 Preparation of thioarabinofuranosyl compounds and use thereof |
| 02/03/2000 | WO2000004865A2 Synthetic techniques and intermediates for polyhydroxy, dienyl lactone derivatives |
| 02/03/2000 | WO2000004863A2 Use of recombinant human uteroglobin in treatment of inflammatory and fibrotic conditions |
| 02/03/2000 | WO1999065922A3 Prenyl transferase inhibitors |
| 02/03/2000 | WO1999065517A3 Therapeutic compositions that produce an immune response by altering the antigen |
| 02/03/2000 | WO1999064464A3 Method for producing or enhancing a t-cell response against a target cell using a complex comprising an hla class i molecule and an attaching means |
| 02/03/2000 | WO1999063942A3 Isolation and structural elucidation of the human cancer cell growth inhibitory compound denominated 'agelagalastatin' |
| 02/03/2000 | WO1999061444A3 Bicyclic pyrimidines and bicyclic 3,4-dihydropyrimidines as inhibitors of cellular proliferation |
| 02/03/2000 | WO1999061097A3 Alpha emitting constructs and uses thereof |
| 02/03/2000 | WO1999061052A3 Oral immunization with papillomavirus virus-like particles |
| 02/03/2000 | WO1999059620A9 Angiostatin receptor |